Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. The Company's medicines are helping numerous patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.
Company Growth (employees)
Type
Public
HQ
New York, US
Founded
1887
Size (employees)
25,000 (est)
Website
bms.com
Bristol-Myers Squibb was founded in 1887 and is headquartered in New York, US

Key People/Management at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chief Executive Officer
Charles Bancroft

Charles Bancroft

Executive Vice President, CFO
Francis Cuss

Francis Cuss

Executive Vice President and Chief Scientific Officer
Lamberto Andreotti

Lamberto Andreotti

Chairman, Board of Directors

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in New York, Jacksonville, Atlanta, Birmingham and in 176 other locations
New York, US (HQ)
345 Park Avenue
Show all (181)

Bristol-Myers Squibb Financials and Metrics

Bristol-Myers Squibb Financials

Bristol-Myers Squibb's revenue was reported to be $19.4 b in FY, 2016
USD

Revenue (Q3, 2017)

5.3 b

Gross profit (Q3, 2017)

3.7 b

Gross profit margin (Q3, 2017), %

70%

Net income (Q3, 2017)

856 m

Market capitalization (11-Dec-2017)

103.3 b

Cash (30-Sep-2017)

4.6 b

EV

105.6 b
Bristol-Myers Squibb's current market capitalization is $103.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

16.4 b15.9 b16.6 b19.4 b

Revenue growth, %

(3%)4%17%

Cost of goods sold

4.6 b3.9 b3.9 b4.9 b

Gross profit

11.8 b11.9 b12.7 b14.5 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

4.1 b3.8 b3.9 b3.9 b4 b4.2 b4.1 b4.4 b4.9 b4.9 b4.9 b5.1 b5.3 b

Cost of goods sold

1.2 b968 m991 m1 b847 m1 b1.1 b1.1 b1.2 b1.3 b1.3 b1.6 b1.6 b

Gross profit

2.9 b2.8 b2.9 b2.9 b3.2 b3.2 b3 b3.3 b3.7 b3.6 b3.7 b3.6 b3.7 b

Gross profit Margin, %

71%75%75%74%79%76%73%76%75%73%74%70%70%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.6 b5.6 b2.4 b4.2 b

Inventories

1.5 b1.6 b1.2 b1.2 b

Current Assets

18.9 b14.6 b10.4 b13.7 b

Goodwill

7.1 b7 b6.9 b6.9 b
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

4.2 b4 b2.6 b2.9 b3.4 b3.9 b3.5 b4.6 b

Inventories

1.3 b1.1 b1.3 b1.4 b1.5 b1.4 b1.2 b1.3 b

Current Assets

13.1 b12.9 b11.2 b12.3 b13.2 b13.6 b14.3 b15 b

Goodwill

7 b7 b6.9 b6.9 b6.9 b6.9 b6.9 b6.9 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2 b1.6 b4.5 b

Inventories

(45 m)(254 m)97 m(152 m)

Accounts Payable

412 m(44 m)(919 m)104 m

Cash From Operating Activities

3.5 b3.1 b1.8 b2.9 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

1.8 b936 m1.3 b2 b1.2 b1.1 b1.8 b1.2 b2.4 b3.6 b1.5 b2.4 b3.3 b

Inventories

(8 m)(144 m)(157 m)(162 m)51 m162 m231 m(44 m)(111 m)(107 m)(71 m)(58 m)7 m

Accounts Payable

301 m(12 m)(112 m)63 m(83 m)(618 m)(1.2 b)(77 m)(36 m)(142 m)(114 m)(85 m)63 m

Cash From Operating Activities

2.1 b1.7 b2.6 b626 m697 m1.2 b25 m1.4 b2.4 b4.2 b
USDY, 2017

EV/CFO

25.4 x

EV/FCF

31.5 x

Revenue/Employee

210.2 k

Financial Leverage

2.3 x
Show all financial metrics

Bristol-Myers Squibb Operating Metrics

Y, 2015Y, 2016

Phase III Trials

28

Projects in R&D Pipeline

3244
Show all operating metrics

Bristol-Myers Squibb Market Value History

Bristol-Myers Squibb Median Salaries

Source: 359 public H-1B filings from Bristol-Myers Squibb

Bristol-Myers Squibb's Web-traffic and Trends

Bristol-Myers Squibb Online and Social Media Presence

Bristol-Myers Squibb Company Life and Culture

You may also be interested in